Over-expression of receptor activator of nuclear factor-κB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty

被引:48
|
作者
Wang, Chen-Ti [1 ,2 ]
Lin, Yu-Tsan [2 ,3 ]
Chiang, Bor-Luen [2 ,3 ]
Lee, Shiou-Shia [2 ,3 ]
Hou, Sheng-Mou [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Orthoped, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan
关键词
Osteolysis; Arthroplasty; Receptor activator of nuclear factor-kappa B ligand (RANKL); Cytokine; Chemokine; BONE-RESORPTION; OSTEOCLAST DIFFERENTIATION; INTERFACE TISSUE; SYNOVIAL-FLUID; WEAR DEBRIS; OSTEOPROTEGERIN; REPLACEMENT; MACROPHAGES; PROSTHESES; PARTICLES;
D O I
10.1016/j.biomaterials.2009.09.017
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Loosening of total hip arthroplasty (THA) caused by periprosthetic osteolysis induced by ultra-high molecular weight polyethylene (UHMWPE) particles is a major clinical problem. We investigated whether there are differences between loosened THA patients and primary THA patients in (1) receptor activator of nuclear factor-kappa B ligand (RANKL) expression on periprosthetic bone marrow cells; (2) RANKL levels, osteoprotegerin (OPG)/RANKL ratios, the levels of inflammatory cytokines and chemokines in synovial fluid. We used flow cytometric analysis to detect RANKL expression on periprosthetic bone marrow cells. We used enzyme-linked immunoassay and multiplex microsphere-based immunoassay to measure RANKL, OPG, cytokines, and chemokines in synovial fluid. We found loosened THA patients had higher RANKL expression on osteoblastic stromal cells, higher levels of RANKL, interleukin (IL)-6, IL-8, IL-10, interferon-gamma-inducible protein (IP)-10, monocyte chemoattractant protein (MCP)-1, monokine induced by interferon-gamma (MIG), and lower OPG/RANKL ratios in synovial fluid than primary THA patients. There was positive correlation between the levels of IL-6, IL-8, IL-10, IP-10, MCP-1, or MIG and RANKL levels in synovial fluid or RANKL expression on osteoblastic stromal cells. These suggest that UHMWPE particles induce over-expression of RANKL, IL-6, IL-8, IP-10, MCP-1, and MIG in human periprosthetic microenvironment. This results in periprosthetic osteolysis and loosening of THA. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [21] Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media
    Kuczkowski, Jerzy
    Sakowicz-Burkiewicz, Monika
    Izycka-Swieszewska, Ewa
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2010, 31 (06) : 404 - 409
  • [22] Inhibition of receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclast formation by pyrroloquinoline quinine (PQQ)
    Odkhuu, Erdenezaya
    Koide, Naoki
    Haque, Abedul
    Tsolmongyn, Bilegtsaikhan
    Naiki, Yoshikazu
    Hashimoto, Shoji
    Komatsu, Takayuki
    Yoshida, Tomoaki
    Yokochi, Takashi
    IMMUNOLOGY LETTERS, 2012, 142 (1-2) : 34 - 40
  • [23] Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
    Rinotas, Vagelis
    Liepouri, Fotini
    Ouzouni, Maria-Dimitra
    Chalkidi, Niki
    Papaneophytou, Christos
    Lampropoulou, Mariza
    Vidali, Veroniki P.
    Kontopidis, George
    Couladouros, Elias
    Eliopoulos, Elias
    Papakyriakou, Athanasios
    Douni, Eleni
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [24] Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women
    Toriola, Adetunji T.
    Appleton, Catherine M.
    Zong, Xiaoyu
    Luo, Jingqin
    Weilbaecher, Katherine
    Tamimi, Rulla M.
    Colditz, Graham A.
    CANCER PREVENTION RESEARCH, 2018, 11 (12) : 789 - 796
  • [25] Evaluation of Isoflavones as Bone Resorption Inhibitors upon Interactions with Receptor Activator of Nuclear Factor-κB Ligand (RANKL)
    Zaklos-Szyda, Malgorzata
    Budryn, Grazyna
    Grzelczyk, Joanna
    Perez-Sanchez, Horacio
    Zyzelewicz, Dorota
    MOLECULES, 2020, 25 (01):
  • [26] Receptor activator of nuclear factor-?B ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice
    Sakai, Nozomu
    Van Sweringen, Heather L.
    Schuster, Rebecca
    Blanchard, John
    Burns, Justin M.
    Tevar, Amit D.
    Edwards, Michael J.
    Lentsch, Alex B.
    HEPATOLOGY, 2012, 55 (03) : 888 - 897
  • [27] Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes
    Gendron, Steve
    Chamoux, Estelle
    Couture, Julie
    Aoudjit, Fawzi
    INFLAMMATION RESEARCH, 2005, 54 : S131 - S131
  • [28] Collagen type I signaling reduces the expression and the function of human receptor activator of nuclear factor-κB ligand (RANKL) in T lymphocytes
    Gendron, S
    Couture, J
    Aoudjit, F
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (12) : 3673 - 3682
  • [29] Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-κB ligand in girls with anorexia nervosa
    Ostrowska, Zofia
    Ziora, Katarzyna
    Oswiecimska, Joanna
    Marek, Bogdan
    Swietochowska, Elzbieta
    Kajdaniuk, Dariusz
    Strzelczyk, Joanna
    Cieslicka, Anna
    Wolkowska-Pokrywa, Kinga
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2015, 66 (04) : 313 - 321
  • [30] Hedgehog signaling enhances core-binding factor a1 and receptor activator of nuclear factor-κB ligand (RANKL) gene expression in chondrocytes
    Takamoto, M
    Tsuji, K
    Yamashita, T
    Sasaki, H
    Yano, T
    Taketani, Y
    Komori, T
    Nifuji, A
    Noda, M
    JOURNAL OF ENDOCRINOLOGY, 2003, 177 (03) : 413 - 421